Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer-Reference-Cited by-同舟云学术

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

Published:2018-07-18 Issue:7 Volume:153 Page:e180996
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Margonis Georgios Antonios¹,Buettner Stefan¹²,Andreatos Nikolaos¹,Kim Yuhree¹,Wagner Doris³,Sasaki Kazunari⁴,Beer Andrea⁵,Schwarz Christoph⁵,Løes Inger Marie⁶⁷,Smolle Maria⁸,Kamphues Carsten⁹,He Jin¹,Pawlik Timothy M.¹⁰¹¹,Kaczirek Klaus⁵,Poultsides George¹²,Lønning Per Eystein⁶⁷,Cameron John L.¹,Burkhart Richard A.¹,Gerger Armin⁸,Aucejo Federico N.⁴,Kreis Martin E.⁹,Wolfgang Christopher L.¹,Weiss Matthew J.¹

Affiliation:

1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Department of Surgery, Erasmus MC University Medical Center, Rotterdam, the Netherlands

3. Department of General Surgery, Medical University of Graz, Graz, Austria

4. Department of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio

5. Department of General Surgery, Medical University of Vienna, Vienna, Austria

6. Department of Clinical Science, University of Bergen, Bergen, Norway

7. Department of Oncology, Haukeland University Hospital, Bergen, Norway

8. Division for Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

9. Department of General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin, University of Berlin–Charité, Berlin, Germany

10. Department of Surgery, The Ohio State University Wexner Medical Center, Columbus

11. Deputy Editor, JAMA Surgery

12. Department of Surgery, Stanford University School of Medicine, Stanford, California

Publisher

American Medical Association (AMA)

Subject

Surgery

Reference41 articles.

1. KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?;Søreide;Cancer,2014

2. Association between specific mutations in KRAS codon 12 and colorectal liver metastasis.;Margonis;JAMA Surg,2015

3. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.;Margonis;Cancer,2016

4. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.;Vauthey;Ann Surg,2013

5. Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.;Frankel;Cancer,2017

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases;Journal of Proteome Research;2024-09-12

2. Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study;British Journal of Surgery;2024-07

3. Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases;Cancers;2024-06-28

4. The Ugly: Metastatic Colon Cancer—Surgical Options;Clinics in Colon and Rectal Surgery;2024-06-18

5. Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients;Journal of Gastrointestinal Cancer;2024-05-06